StonvexLoading…
StonvexStonvexStonvexCore line items from CLVT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.46B | $2.56B | $2.63B | $2.66B |
Operating Income | $71.50M | $-275.60M | $-734.70M | $-3.93B |
Net Income | $-201.10M | $-636.70M | $-911.20M | $-3.96B |
EPS (Diluted) | $-0.30 | $-0.96 | $-1.47 | $-6.24 |
Total Assets | $11.07B | $11.49B | $12.71B | $13.94B |
Total Liabilities | $6.23B | $6.35B | $6.71B | $7.13B |
Cash & Equivalents | $329.20M | $295.20M | $370.70M | $356.80M |
Free Cash Flow OCF − CapEx | $365.30M | $357.50M | $501.70M | $306.40M |
Shares Outstanding | 640.70M | 691.40M | 666.10M | 674.40M |